Improved antitumor effects elicited by an oncolytic HSV-1 expressing a novel B7H3nb/CD3 BsAb.
Zhang Z, Yang N, Lu H, Chen Y, Xu L, Wang Z, Lu Q, Zhong K, Zhu Z, Wang G, Li H, Zheng M, Zhang W, Yang H, Peng X, Zhou L, Tong A.
Zhang Z, et al. Among authors: yang n, yang h.
Cancer Lett. 2024 Apr 28;588:216760. doi: 10.1016/j.canlet.2024.216760. Epub 2024 Feb 29.
Cancer Lett. 2024.
PMID: 38428724